Precision Medicine with Polypharmacy in Multiple Sclerosis: What does it mean in practice?

Access Activity

Overview / Abstract:

Target Audience

Neurologists, primary care physicians, advance practice clinicians, nursing professionals, pharmacists, and other healthcare professionals involved in the care of patients with MS.

Learning Objectives

Summarize approaches to providing personalized medicine for MS diagnosis and management while minimizing drug interactions with medications for common comorbidities
Appraise current data on biomarkers for differentiating MS from other disorders and MS phenotypes
Evaluate algorithms and predictive models for MS management

Expiration

Sep 14, 2021

Discipline(s)

Nursing CNE, Pharmacy CPE, Physician CME

Format

Online

Credits / Hours

1.0 AMA PRA Category 1 Credit(s)™

Accreditation

ACCME

Presenters / Authors / Faculty

Faculty

Jacquelyn L. Bainbridge, PharmD, FCCP, MSCS, FAES

Marijean Buhse, PhD, RN, NP-C, MSCN

Robert K. Shin, MD, FANA, FAAN

June Halper, MSN, APN-C, MSCN, FAAN

Laurie Scudder, DNP, NP

Sponsors / Supporters / Grant Providers

BioGen, Genetech and Sanofi Genzyme

Keywords / Search Terms

Relias LLC Relias LLC., FREE CME., Multiple Sclerosis Free CE CME

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map